During cell division, genetic integrity is maintained by ensuring that all chromosomes are attached to microtubules emanating from both poles of the mitotic spindle before segregation of sister chromatids begins (1) . This process is monitored by the mitotic checkpoint, which prevents initiation of anaphase until every kinetochore is attached and tension between kinetochores of paired sister chromatids is sufficient, ensuring biorientation (2) . To prevent aneuploidy and ensuing genetic defects leading to cell death or tumourigenesis (3), the mitotic checkpoint must be sufficiently sensitive to delay chromosome separation when even one kinetochore is unattached. Exposure to drugs that interfere with microtubule dynamics, such as the taxanes (4) and the vinca alkaloids (5) , similarly activates the mitotic checkpoint and arrests cells at mitosis, effectively preventing further proliferation.
The mitotic checkpoint acts through inhibition of the anaphase-promoting complex/cyclosome (APC/C) (6), the E3 ubiquitin ligase (7) that, when activated by cofactors Cdc20 or Cdh1 (8) , polyubiquitylates the Cdk1 cofactor cyclin B1 (7) and the separase regulator securin (9) , targeting them for degradation by the proteasome. This results in Cdk1 inactivation, separation of sister chromatids, and exit from mitosis. The key components of the mitotic checkpoint are BubR1, Bub3, and Cdc20, which form a 'mitotic checkpoint complex' (MCC) (10) that is the main inhibitor of APC/C activity, and Mad2, which initially binds Cdc20 (11) and catalyzes its binding to BubR1 and subsequent formation of the MCC (12) . Cdc20 is an activating cofactor of APC/C during mitosis (8) ; an active mitotic checkpoint inhibits APC/C through APC/C-dependent polyubiquitylation of Cdc20 and subsequent degradation by the proteasome (12) . BubR1 binds to and inhibits both Cdc20 (13) and APC/C itself (14) , acting as a pseudosubstrate inhibitor that, depending on acetylation status, can be actively degraded by APC/C Cdc20 (15) . The role of Bub3 in the MCC is unclear, although in fission yeast it is involved (16) . Other components of the mitotic checkpoint include the kinases Bub1, Mps1, and Aurora B (2).
Caspases have well-characterized apoptotic functions, but caspase-3 and caspase-7 have both recently been observed to play a role, yet to be defined, in mitotic progression (17, 18) .
Their activities are tightly regulated and must be restrained during mitotic stress to prevent extensive cell death, most notably through survivin, which inhibits caspase activation during mitotic arrest and functions as part of the mitotic checkpoint machinery (19) .
Mitotic checkpoint activation during an unperturbed mitosis provides sufficient time for microtubule attachment, preventing aneuploidy (20) and increasing cell survival (21) . However, long-term activation of the mitotic checkpoint during exposure to antimitotic agents can be problematic because chomosome condensation hinders RNA transcription (22) . With time, an imbalance between new protein production and protein degradation may cause the levels of proteins essential to maintain mitotic arrest to fall, triggering mitotic slippage. Also termed mitotic checkpoint adaptation, mitotic slippage occurs when cells exit mitosis without chromosome segregation or cell division (20, 23) and results from slow APC/C Cdc20 -and proteasome-dependent degradation of cyclin B1 in the presence of an active mitotic checkpoint (24, 25) . Cells that have undergone mitotic slippage enter a G1-like state with decondensed chromosomes that form multiple micronuclei (23) , allowing resumption of transcription and other cellular processes.
Our group and others have identified chemicals that stimulate mitotic slippage and observed that slipped cells typically undergo at least one round of DNA replication without subsequent cell division but that, eventually, all cells that undergo mitotic slippage die (26) (27) (28) (29) (30) .
Known chemical inducers of mitotic slippage include CDK1 inhibitors (roscovitine, RO3066 Fig. 1 ). We previously identified SU6656 and geraldol as chemical inducers of mitotic slippage that increased cell killing after induction of mitotic arrest by microtubuletargeting agents. This study investigates how chemicals can modulate mitotic slippage, reveals a mechanism for mitotic slippage that is different from that described for spontaneous mitotic slippage, and shows how interplay between pathways associated with mitosis and apoptosis can contribute to the outcome of antimitotic cancer treatments.
Materials and Methods
Cell culture and chemicals-T98G cells, obtained from the American Type Culture Collection (characterized by short tandem repeat analysis) and used within six months of resuscitation, were maintained in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (Gibco). MCF-7 cell lines, obtained from the American Type Culture Collection and stably transfected with empty vector (pcDNA) or caspase-3 (casp3), were maintained in RPMI (Invitrogen) supplemented with 10% fetal bovine serum and 10 mM HEPES, pH 7.3 (Invitrogen). Paclitaxel was obtained from USB, SU6656 and MG-132 from Sigma, geraldol from Chromadex, and cellpermeable DEVD-CHO from Enzo Life Sciences.
Slippage induction assay-T98G cells at 75% confluency were treated with 30 nM paclitaxel, or MCF-7 cells were treated with 50 nM paclitaxel, for 20 h at 37ÛC and mitotic cells were harvested by shake-off, counted using a hemacytometer, seeded in a 96-well plate (PerkinElmer Viewplate) at 5,000 cells/well, and treated with chemicals as indicated for 4 h at 37ÛC. Hoechst 33342 (Invitrogen) in PBS for 10 min at room temp. 5 fields per well were counted by a Cellomics ArrayScan VTI automated fluorescence imager (ThermoFisher) using a 10x objective.
Individual nuclei of slipped cells were detected and counted using the Cellomics Target Activation analysis program. In all figures, mitotic slippage was expressed as a percentage of the cells seeded in each well (26) .
Immunoblotting-Cells were washed in PBS and lysed for 5 min on ice in lysis buffer containing 20 mM Tris-HCl (Fisher), pH 7.5, 150 mM NaCl (Fisher), 1 mM EDTA (Sigma), 1 mM EGTA (Sigma), 1% Triton X-100 (LabChem Inc.), 2.5 mM sodium pyrophosphate (Fisher), 1 mM ß-glycerolphosphate (Sigma), 1 mM sodium orthovanadate (Sigma) and 1x protease inhibitor cocktail (Roche). Lysates were spun at 15,000 x g for 15 min and supernatants were removed and assayed for protein concentration using the Bradford assay (Sigma). Sample concentration was equalized and diluted in 50 mM Tris-HCl (Fisher), pH 6. Antibodies used were mouse α-cyclin B1 (1:100, BD Pharmingen), mouse α-BubR1 (1:1000, BD Transduction), mouse α-Mad2 (1:500, Santa Cruz), mouse α-p55CDC/Cdc20 (1:1000, Santa Cruz), mouse α-Mps1 (1:500, Abcam), goat α-mouse HRP (1:10,000), and goat α-rabbit peroxidase conjugate (1:10,000). the radioactivity on the plate was counted using a Trilux scintillation counter against a control incubated without substrate.
Results

Induction of mitotic slippage by SU6656 and geraldol requires proteasomal activity. A previous
screening effort by our group identified SU6656 and geraldol as chemicals capable of inducing mitotic slippage (26) . When cells spontaneously slip out of mitotic arrest, as well as during normal exit from mitosis, proteasomal activity is required for the degradation fo cyclin B1 (24, 25) . First, to determine whether escape from mitotic arrest induced by SU6656 or geraldol similarly requires proteasome activity, mitotic slippage was examined in the presence of the proteasome inhibitor MG-132. T98G cells at 75% confluency were arrested in mitosis by (Fig. 1B) . Therefore, induction of mitotic slippage by these chemicals is similar to normal exit from mitosis and spontaneous slippage with respect to proteasome dependence and cyclin B1 degradation.
Induction of mitotic slippage involves proteasome-dependent degradation of mitotic checkpoint
proteins. Although spontaneous mitotic slippage occurs via the degradation of cyclin B1 by APC/C Cdc20 , it does not involve inactivation of the mitotic checkpoint (24, 25) . Using immunoblotting, the effects of SU6656 and geraldol on the cellular levels of the main mitotic checkpoint mediators Cdc20, BubR1, Mad2 and Mps1 were examined. Levels of these proteins increased in cells arrested in mitosis (Fig. 1B) and subsequent exposure to SU6656 and geraldol caused complete degradation of BubR1 and Cdc20 and a sizeable reduction in Mps1 levels. The degradation of these three proteins was prevented by co-incubation with MG-132 (Fig. 1B ).
Exposure to SU6656, but not geraldol, decreased cellular levels of Mad2 and this depletion was not proteasome-dependent (Fig. 1B) .
In T98G cells, BubR1 is not degraded during completion of mitosis ( Supplementary Fig. 2 ),
indicating that its degradation in cells induced to undergo mitotic slippage by SU6656 or geraldol is not simply a normal consequence of exiting mitosis. Depletion of BubR1 or Mps1 has previously been shown to be sufficient to inactivate the mitotic checkpoint (14, 35, 36) . Therefore, our results imply that SU6656 and geraldol induce mitotic slippage through degradation of mitotic checkpoint proteins.
SU6656 and geraldol do not induce the degradation of cyclin B1, BubR1 or Cdc20 in interphase
cells. To determine whether SU6656 and geraldol induce the proteasome-dependent degradation of cyclin B1, BubR1 and Cdc20 in interphase as well as in mitotic cells, proliferating T98G cells, which comprise 98% interphase cells, were exposed to 5 μM SU6656 or 5 μM geraldol for 4 h and analysed by immunoblotting. No decrease in the levels of cyclin B1, BubR1 or Cdc20 was observed (Fig. 1C) ; rather, a slight increase in the levels of all three proteins was observed.
Simultaneous treatment with 20 μM MG-132 had no additional effect (Fig. 1C) . These results indicate that an active mitotic checkpoint is required for SU6656-and geraldol-induced selective degradation of mitotic checkpoint components.
Mitotic checkpoint inactivation and slippage induction by SU6656 and geraldol require caspase-
3.
Caspases have been implicated in mitotic progression (18) , and in particular, BubR1 is reportedly degraded by the effector caspase-3 during exit from mitosis (17), although we did not observe this effect in T98G cells (Supplementary Fig. 2 ). To determine whether mitotic slippage induced by SU6656 and geraldol involves caspase-3, paclitaxel-arrested T98G cells harvested via shake-off were exposed to 5 μM SU6656 or 5 μM geraldol concurrently with cell-permeable DEVD-CHO, an inhibitor of caspases-3 and -7, for 4 h. DEVD-CHO prevented induction of mitotic slippage at 50 -100 μM ( Fig. 2A) , indicating a requirement for caspase activity in mitotic slippage induction by SU6656 and geraldol. Immunoblotting of paclitaxel-arrested T98G cells exposed to SU6656 or geraldol together with 50 μM DEVD-CHO revealed that degradation of BubR1 and Cdc20 is caspase-dependent ( Fig. 2A ) in addition to being proteasome-dependent (Fig. 1B) . In contrast, cyclin B1 degradation during induction of mitotic slippage is not dependent on caspase-3 or caspase-7 ( Fig. 2A) , as co-treatment with DEVD-CHO did not prevent cyclin B1 degradation in response to SU6656 or geraldol.
We previously observed that MCF-7 cells do not undergo mitotic slippage, spontaneous (26) or induced by SU6656 or geraldol (not shown). MCF-7 cells do not express caspase-3 due to a deletion within exon 3 of the CASP-3 gene that results in the introduction of a premature stop codon that completely abrogates translation of the CASP-3 mRNA (37). This observation was utilised to determine whether caspase-3 is required for mitotic slippage induction by SU6656 and geraldol; the inability of these chemicals to stimulate mitotic slippage in MCF-7 cells could be due to lack of caspase-3 activity. Indeed, SU6656 and geraldol did not induce mitotic slippage in MCF-7 cells stably transfected with an empty expression vector (MCF7pcDNA) (Fig. 2B) . However, stable transfection of CASP-3 cDNA into MCF-7 cells (MCF7casp3), which results in expression of pro-caspase-3 (37), was sufficient to enable cells to undergo robust mitotic slippage in the presence of SU6656 or geraldol (Fig. 2B) . Therefore, caspase-3 is required for induction of mitotic slippage by these chemicals.
We next asked whether there were differences in the degradation of cyclin B1, BubR1 and Cdc20 in MCF-7pcDNA and MCF-7casp3 cells during exposure to SU6656 and geraldol.
Paclitaxel-arrested MCF-7pcDNA and MCF-7casp3 cells were harvested via shake-off, exposed to 5 μM SU6656 or 5 μM geraldol for 4 h and analysed by immunoblotting (Fig. 2B) . Cyclin B1 was completely degraded in both cell lines upon exposure to either SU6656 or geraldol. Since MCF-7pcDNA cells do not undergo mitotic slippage under these conditions, while MCF-7casp3 cells do, this result implies that cyclin B1 degradation is not sufficient to induce mitotic slippage.
Cdc20 was degraded in both MCF-7pcDNA and MCF-7casp3 cells. Interestingly, BubR1 was degraded only in MCF-7casp3 cells (Fig. 2B) , implying that BubR1 is degraded in a caspase-3- (Fig. 2B) , further indicating that it is caspase-3 and not the proteasome that is required for the degradation of BubR1 during induction of mitotic slippage. Cdc20 degradation was proteasome-dependent but the degradation of cyclin B1 was not (Fig. 2B) . Taken together, these results indicate that SU6656 and geraldol stimulate the degradation of BubR1 by caspase-3, inactivating the mitotic checkpoint and resulting in mitotic slippage.
Approximately 20% of MCF-7pcDNA cells underwent mitotic slippage in the absence of SU6656 and geraldol (Fig. 2B) , indicating that spontaneous mitotic slippage does not require caspase-3. To extend this observation, mitotic arrest and slippage in MCF-7pcDNA and MCF7casp3 cells were examined during exposure to paclitaxel. Cells were exposed to 100 nM paclitaxel for up to 28 h and the proportion of interphase, mitotic and slipped cells was determined (Fig. 2C) . In both cell lines, mitotic and slipped cells accumulated over time as the proportion of interphase cells declined (Fig. 2C) . After 24 h, the proportion of slipped cells became greater than that of mitotic cells. The kinetics of accumulation of mitotic cells and slipped cells were very similar in MCF-7pcDNA and MCF-7casp3 cells (Fig. 2C) , confirming that caspase-3 is not required for mitotic arrest or spontaneous slippage in response to paclitaxel. antimitotic agents, it is absolutely required for mitotic slippage induction by SU6656 and geraldol.
Mitotic slippage correlates temporally with degradation of BubR1 and Cdc20.
To examine the timing of chemically induced exit from mitosis, paclitaxel-arrested mitotic cells were harvested by shake-off, seeded in 96-well plates, and exposed to geraldol for up to 3 h while cell attachment and TG3 fluorescence were measured (Fig. 3A) . TG3 recognizes nucleolin phosphorylated by Cdk1/cyclin B1 and is a marker for mitosis (38) . A significant proportion of cells began to attach after 2 h of exposure to geraldol, and the proportion of attached cells continued to increase over time (Fig. 3A, left) . TG3 fluorescence decreased appreciably within 60 min of exposure to geraldol and continued to decrease over time (Fig. 3A, right) . TG3 fluorescence during exposure to SU6656 could not be measured due to autofluorescence of the compound. The timing of degradation of cyclin B1, BubR1 and Cdc20 during mitotic slippage was also examined. Paclitaxel-arrested cells were exposed to 5 μM SU6656 or 5 μM geraldol for 15 min to 3 h. Cyclin B1 disappeared completely within 30 min (Fig. 3B ). BubR1 and Cdc20 were partially degraded within 15 min of exposure and almost completely degraded after about 2 h (Fig. 3B) , around the time when cells began to attach and lose nucleolin phosphorylation, consistent with a requirement for degradation of BubR1 and Cdc20 for mitotic slippage.
Inhibition of the Aurora kinases by SU6656 and geraldol.
The Aurora kinases play complex roles in metaphase arrest and anaphase initiation, including chromosome congression and interkinetochore tension sensing (39, 40) . Inhibition of Aurora A or Aurora B in mitotic cells results in mitotic slippage (33, 34) . SU6656 was designed as a Src family kinase inhibitor (41), but has since been reported to inhibit Aurora B in vitro (42, 43) . Geraldol has no known biological activity, but fisetin, a closely structurally related flavonoid that induces mitotic slippage less potently than geraldol ( Supplementary Fig. 3 ), has also been reported to inhibit Aurora B (30) . Geraldol was assayed for in vitro inhibition of a panel of kinases including Src, Aurora A and Aurora B (Supplementary Table 1 ) and showed significant inhibition of Aurora A and Aurora B but not Src. SU6656 and geraldol were then assayed at 0.1-10 μM for inhibition of Aurora A and Aurora B kinase activity (Fig. 4A ). Both compounds inhibited Aurora A and Aurora B, although Aurora B was inhibited more potently. The intracellular effects of SU6656 and geraldol were compared with those of ZM447439, a well-characterized Aurora B inhibitor that induces mitotic slippage (33) . ZM447439 induces 50-60% of mitotic MCF-7 cells to undergo mitotic slippage (Fig. 4B) , while SU6656 and geraldol require the introduction of caspase-3 to induce mitotic slippage in MCF-7 cells (Fig. 2C) . Thus, mitotic slippage induction through inhibition of Aurora B does not appear to require caspase-3 activation. Therefore, while SU6656 and geraldol may stimulate mitotic slippage in part by inhibition of Aurora B, these compounds probably have additional activities.
Cell survival after mitotic slippage is not affected by caspase-3.
Given the role that caspase-3 plays in apoptosis and in mitosis (44, 45) , induction of mitotic slippage may affect the survival of cells lacking and expressing caspase-3 differently. MCF-pcDNA and MCF-7casp3 cells arrested at mitosis with paclitaxel were harvested via shake-off and exposed to DMSO, SU6656 or geraldol for 4 h. Unattached mitotic cells were removed and the attached, slipped cells were cultured in the absence of any drugs for up to 14 d while cell numbers were determined by automated fluorescence microscopy (Fig. 5A) . Extensive cell death occurred in both cell lines such that, 14 d after mitotic slippage, fewer than 20% of the initial number of mitotic cells remained (Fig. 5A) . Therefore, caspase-3 expression does not appear to play a major role in cell survival after mitotic slippage. The fate of the entire cell population after exposure to paclitaxel and SU6656 or geraldol was also examined. MCF-7pcDNA and MCF-7casp3 cells were exposed to 50 nM paclitaxel for 20 h and 0.1% DMSO, 5 μM SU6656 or 5 μM geraldol was added for a further 4 h before both drugs were washed away. The cells were then allowed to grow in fresh cell culture medium for up to 10 d prior to staining and quantification. Initially, a small increase in cell number was observed, indicating that some cells recovered and were able to divide (Fig. 5B) . However, extensive cell death began to occur 5 d following drug treatment and the majority of cells died before day 10 ( Fig. 5B) . Caspase-3 expression did not alter this response.
We previously reported that, after undergoing mitotic slippage, cells remained metabolically active for up to several days and underwent one or more rounds of DNA replication without cell division before undergoing apoptosis (26) . MCF-7pcDNA and MCF7casp3 cells were treated as above and metabolic activity was examined using the MTT assay.
The metabolic activity of treated cells in both cell lines increased during the first three days to roughly the same extent as untreated cells (Fig. 5C) , although untreated cells proliferated rapidly during that time and there was a minimal increase in number of treated cells (Fig. 5B) . Metabolic activity reached a plateau after 3 d and decreased considerably after 7 d, a response not altered by caspase-3 expression. This result indicates that, for 3 d after treatment with paclitaxel without or with SU6656 or geraldol, little or no cell proliferation or death took place, but the cells continued to grow in size. Cell growth was arrested between 3 and 7 d before extensive cell death took place after day 7.
Discussion
This study aimed to better understand pathways leading to mitotic slippage through the use of chemicals. SU6656 and geraldol, two compounds found to stimulate mitotic slippage in 
cells exposed to a microtubule-targeting agent (26) , induce the proteasome-dependent degradation of cyclin B1 as occurs during exit from mitosis (Fig. 1B) (46) . However, these chemicals inactivate the mitotic checkpoint through the proteasome-dependent degradation of BubR1 (Fig. 1B) that is sufficient to compromise the mitotic checkpoint (35, 36, 47) . This effect occurs only in mitotic cells (Fig. 1C) , and BubR1 is not degraded during completion of mitosis in T98G cells (Supplementary Fig. 2 ). These results suggest that, rather than accelerating spontaneous mitotic slippage, SU6656 and geraldol activate an alternate pathway leading to mitotic slippage through BubR1 degradation.
Examination of the timing of mitotic checkpoint inactivation and slippage revealed that mitotic slippage, defined in this experiment by cell attachment and loss of the mitotic phosphoepitope recognized by the TG3 antibody, begins to occur 2 h following exposure to geraldol, while cyclin B1 degradation is complete 30 min after drug treatment (Fig. 3A,B ).
BubR1 and Cdc20 degradation occur more slowly (Fig. 3B ) and approximately correlate with mitotic slippage, indicating a possible requirement for checkpoint inactivation prior to mitotic slippage, even in the absence of Cdk1/cyclin B1 activity. In agreement with this observation, cyclin B1 is also completely degraded in MCF-7 cells in response to SU6656 and geraldol, although mitotic slippage cannot be induced (Fig. 2B) . It is not known whether the degradation of other APC/C substrates or dephosphorylation of mitotic checkpoint kinase substrates might be involved in mitotic slippage.
Caspase-3 is upregulated during mitosis (18) and has been demonstrated to increase the formation of micronuclei in response to antimitotic agents (48), but a role for caspase-3 in mitosis remains undefined. This study reveals a novel role for caspase-3: mitotic slippage induced by SU6656 and geraldol is caspase-3-dependent. Co-treatment of mitotic cells with 
SU6656 or geraldol and the caspase-3 and -7 inhibitor DEVD-CHO prevented mitotic slippage and checkpoint inactivation (Fig. 2A) . While introduction of caspase-3 into MCF-7 cells does not affect the frequency of spontaneous mitotic slippage in response to paclitaxel (Fig. 2C) , mitotic slippage can be induced by SU6656 and geraldol in MCF-7 cells only when exogenous caspase-3 is expressed (Fig. 2B) , indicating that caspase-3 is absolutely required for mitotic slippage induction by SU6656 and geraldol.
This requirement for caspase-3 is likely due to its role in inactivation of the mitotic checkpoint; mitotic slippage and BubR1 degradation occur in MCF-7 cells with active caspase-3 but not in MCF-7 cells lacking caspase-3 (Fig. 2B ). BubR1 degradation is sufficient to inactivate the mitotic checkpoint (14, 35, 36) and, further, depletion of BubR1 by mutation (47) However, caspase-3 does not appear to be required for cell death following paclitaxel treatment (Fig. 5) . While caspase-3 is required for DNA fragmentation during apoptosis (37) , cells that lack caspase-3 can nevertheless undergo apoptosis. Other cell death pathways may also be involved in the fate of cells following exposure to an antimitotic agent: for instance, necrosis and autophagy have both been implicated in cell death following antimitotic therapy (49, 50) .
Spontaneous mitotic slippage has been described to occur through slow ubiquitylation of cyclin B1 by APC/C Cdc20 and subsequent proteasome-dependent degradation despite mitotic checkpoint activity (24, 25) . We propose a model ( for the indicated proteins. E. MCF-7pcDNA or MCF-7casp3 cells were exposed to 100 nM paclitaxel for up to 28 h and nuclei were fixed and stained with Hoechst 33342. The total number of cells was quantified using automated fluorescence microscopy and the images were visually inspected to determine the proportion of slipped and mitotic cells at each time. 
